In a significant move to enhance affordability, Novo Nordisk and GoodRx have announced a partnership that allows patients to purchase the diabetes medication Ozempic...
Biogen Inc. CEO Chris Viehbacher expressed optimism that a successful trial of Novo Nordisk A/S’s weight-loss drug could pave the way for innovative treatments...
URGENT UPDATE: UBS has officially downgraded its rating for Novo Nordisk, the renowned Danish pharmaceutical company behind the blockbuster weight-loss drugs Ozempic and Wegovy....